Core Insights - Neurocrine Biosciences reported quarterly earnings of $2.04 per share, exceeding the Zacks Consensus Estimate of $1.58 per share, and showing an increase from $1.24 per share a year ago, resulting in an earnings surprise of +29.11% [1] - The company achieved revenues of $794.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.73% and up from $622.1 million year-over-year [2] - Neurocrine shares have increased approximately 9.1% year-to-date, while the S&P 500 has gained 16.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.71 on revenues of $785.17 million, and for the current fiscal year, it is $4.49 on revenues of $2.79 billion [7] - The estimate revisions trend for Neurocrine was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Drugs industry, to which Neurocrine belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Amneal Pharmaceuticals, another company in the same industry, is expected to report quarterly earnings of $0.13 per share, reflecting a year-over-year decline of -18.8%, with revenues projected at $773.6 million, up 10.1% from the previous year [9][10]

Core Insights - NeoGenomics reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, but down from $0.05 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company generated revenues of $187.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.27% and increasing from $167.82 million year-over-year [2] - NeoGenomics shares have declined approximately 38.4% year-to-date, contrasting with the S&P 500's gain of 16.9% [3] Earnings Outlook - The future performance of NeoGenomics stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $189.51 million, and for the current fiscal year, it is $0.09 on revenues of $722.29 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which NeoGenomics belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]

Paypal (PYPL) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.61%. A quarter ago, it was expected that this technology platform and digital payments company would post earnings of $1.3 per share when it actually produced earnings of $1.4, delivering a surprise of +7.69%.Over the la ...

Core Insights - Xylem reported quarterly earnings of $1.37 per share, exceeding the Zacks Consensus Estimate of $1.24 per share, and showing an increase from $1.11 per share a year ago, resulting in an earnings surprise of +10.48% [1] - The company achieved revenues of $2.27 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.98% and up from $2.1 billion year-over-year [2] - Xylem's stock has increased by approximately 28.8% since the beginning of the year, outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The future performance of Xylem's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - Current consensus EPS estimate for the upcoming quarter is $1.31 on revenues of $2.37 billion, and for the current fiscal year, it is $4.84 on revenues of $8.96 billion [7] Industry Context - The Waste Removal Services industry, to which Xylem belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, indicating potential challenges ahead [8] - Another company in the same industry, Select Water Solutions, is expected to report a significant decline in earnings, with a projected EPS of $0.05, reflecting a year-over-year change of -66.7% [9]

Core Insights - Tenet Healthcare (THC) reported quarterly earnings of $3.7 per share, exceeding the Zacks Consensus Estimate of $3.33 per share, and up from $2.93 per share a year ago, representing an earnings surprise of +11.11% [1] - The company achieved revenues of $5.29 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.02% and showing an increase from $5.12 billion year-over-year [2] - Tenet shares have increased approximately 71.3% year-to-date, significantly outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.13 on revenues of $5.39 billion, and for the current fiscal year, it is $15.82 on revenues of $21.16 billion [7] - The estimate revisions trend for Tenet was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Hospital industry, to which Tenet belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Zebra Technologies reported quarterly earnings of $3.88 per share, exceeding the Zacks Consensus Estimate of $3.75 per share, and up from $3.49 per share a year ago [1] - The company achieved an earnings surprise of +3.47% for the quarter, having surpassed consensus EPS estimates in all four of the last quarters [2] - Zebra's revenues for the quarter reached $1.32 billion, surpassing the Zacks Consensus Estimate by 0.71% and increasing from $1.26 billion year-over-year [3] Earnings Performance - The earnings surprise of +3.47% indicates strong performance relative to expectations, with a previous quarter surprise of +9.06% [2] - Over the last four quarters, Zebra has consistently exceeded consensus revenue estimates [3] Stock Performance and Outlook - Zebra shares have declined approximately 19.6% year-to-date, contrasting with the S&P 500's gain of 16.9% [4] - The company's future stock performance will largely depend on management's commentary during the earnings call and the outlook for earnings revisions [5][6] Earnings Estimates - Current consensus EPS estimate for the upcoming quarter is $4.23, with expected revenues of $1.38 billion, and for the current fiscal year, the estimate is $15.67 on revenues of $5.29 billion [8] - The estimate revisions trend for Zebra was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [7] Industry Context - Zebra operates within the Manufacturing - Thermal Products industry, which is currently ranked in the top 38% of over 250 Zacks industries, suggesting a favorable industry outlook [9]

Core Insights - Herc Holdings (HRI) reported quarterly earnings of $2.22 per share, exceeding the Zacks Consensus Estimate of $1.83 per share, but down from $4.35 per share a year ago, indicating an earnings surprise of +21.31% [1] - The company generated revenues of $1.3 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.12% and showing a significant increase from $965 million year-over-year [2] - The stock has underperformed, losing approximately 29.6% since the beginning of the year, compared to a 16.9% gain in the S&P 500 [3] Earnings Performance - Over the last four quarters, Herc Holdings has surpassed consensus EPS estimates two times and topped revenue estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is $2.23, with expected revenues of $1.34 billion, and for the current fiscal year, the estimate is $6.32 on $4.46 billion in revenues [7] Market Outlook - The company's earnings outlook is crucial for investors, as it reflects current consensus expectations and any recent changes [4] - The Zacks Rank for Herc Holdings is currently 4 (Sell), indicating expectations of underperformance in the near future [6] - The Transportation - Equipment and Leasing industry, to which Herc Holdings belongs, is ranked in the top 26% of Zacks industries, suggesting a favorable industry outlook [8]

Applied Industrial Technologies (AIT) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.48%. A quarter ago, it was expected that this industrial products company would post earnings of $2.6 per share when it actually produced earnings of $2.8, delivering a surprise of +7.69%.Over the ...

分组1 - Amerant Bancorp Inc. reported quarterly earnings of $0.39 per share, missing the Zacks Consensus Estimate of $0.55 per share, but showing an increase from $0.27 per share a year ago, resulting in an earnings surprise of -29.09% [1] - The company posted revenues of $111.44 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.87% and increasing from $101.8 million year-over-year [2] - Over the last four quarters, Amerant Bancorp has surpassed consensus revenue estimates four times, while it has exceeded consensus EPS estimates two times [2] 分组2 - Amerant Bancorp shares have declined approximately 21.8% since the beginning of the year, contrasting with the S&P 500's gain of 16.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.57 on revenues of $111.87 million, and for the current fiscal year, it is $1.85 on revenues of $436.64 million [7] - The Zacks Industry Rank for Banks - Southeast is currently in the top 26% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

分组1 - V.F. reported quarterly earnings of $0.51 per share, exceeding the Zacks Consensus Estimate of $0.42 per share, but down from $0.6 per share a year ago, resulting in an earnings surprise of +21.43% [1] - The company achieved revenues of $2.8 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.72%, although this is a slight decrease from year-ago revenues of $2.76 billion [2] - V.F. has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has underperformed the market, losing about 22.6% since the beginning of the year compared to the S&P 500's gain of 16.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.56 on revenues of $2.88 billion, and for the current fiscal year, it is $0.74 on revenues of $9.57 billion [7] - The Zacks Industry Rank indicates that the Textile - Apparel sector is currently in the bottom 13% of over 250 Zacks industries, suggesting potential challenges for stocks in this category [8]